Current trials are underway such as VAPOR-C, GA-CARES, VITAL to provide higher level of evidence. https://t.co/JxBRmt426B. Preliminary data from Sweden for 1-year survival is available and no benefit was observed in the propofol-based TIVA group. The jury
RT @juanpcata: Our latest manuscript! Anesthesia Techniques and Long-Term Oncological Outcomes @MF_ramirezMD @mdandersonnews https://t.co…
RT @juanpcata: Our latest manuscript! Anesthesia Techniques and Long-Term Oncological Outcomes @MF_ramirezMD @mdandersonnews https://t.co…
RT @juanpcata: Our latest manuscript! Anesthesia Techniques and Long-Term Oncological Outcomes @MF_ramirezMD @mdandersonnews https://t.co…